DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,856,966 | -14.5% | 136,465 | -17.3% | 0.50% | -11.1% |
| Q2 2023 | $39,613,680 | +13.8% | 165,057 | +19.5% | 0.56% | +3.7% |
| Q1 2023 | $34,799,162 | -1.1% | 138,070 | +4.1% | 0.54% | -10.0% |
| Q4 2022 | $35,199,204 | +17.4% | 132,617 | +14.3% | 0.60% | -3.2% |
| Q3 2022 | $29,970,000 | +22.3% | 116,034 | +20.0% | 0.62% | +0.8% |
| Q2 2022 | $24,513,000 | -13.6% | 96,692 | 0.0% | 0.62% | +6.9% |
| Q1 2022 | $28,363,000 | +4.9% | 96,692 | +17.6% | 0.58% | +10.1% |
| Q4 2021 | $27,042,000 | -1.6% | 82,192 | -8.9% | 0.52% | -8.9% |
| Q3 2021 | $27,470,000 | +13.4% | 90,230 | 0.0% | 0.57% | +16.2% |
| Q2 2021 | $24,214,000 | +19.2% | 90,230 | 0.0% | 0.49% | +2.1% |
| Q1 2021 | $20,309,000 | +1.3% | 90,230 | 0.0% | 0.48% | -6.4% |
| Q4 2020 | $20,044,000 | +3.2% | 90,230 | 0.0% | 0.52% | -17.9% |
| Q3 2020 | $19,429,000 | +21.8% | 90,230 | 0.0% | 0.63% | -4.5% |
| Q2 2020 | $15,955,000 | +4.6% | 90,230 | -18.1% | 0.66% | -16.6% |
| Q1 2020 | $15,257,000 | +89.7% | 110,230 | +110.6% | 0.79% | +94.3% |
| Q4 2019 | $8,043,000 | -8.1% | 52,345 | -13.5% | 0.41% | -2.6% |
| Q3 2019 | $8,749,000 | +4.5% | 60,502 | +3.4% | 0.42% | +4.5% |
| Q2 2019 | $8,372,000 | +18.1% | 58,508 | +9.1% | 0.40% | +9.0% |
| Q1 2019 | $7,086,000 | +19.5% | 53,607 | -6.7% | 0.37% | +1.4% |
| Q4 2018 | $5,932,000 | -7.6% | 57,436 | -2.7% | 0.36% | +17.2% |
| Q3 2018 | $6,423,000 | -45.1% | 59,027 | -50.2% | 0.31% | -23.9% |
| Q2 2018 | $11,706,000 | +22.7% | 118,431 | +21.7% | 0.41% | +19.8% |
| Q1 2018 | $9,542,000 | +1.0% | 97,295 | -4.3% | 0.34% | +5.6% |
| Q4 2017 | $9,450,000 | -11.2% | 101,660 | -17.9% | 0.32% | -14.9% |
| Q3 2017 | $10,643,000 | -6.7% | 123,873 | -8.2% | 0.38% | -11.3% |
| Q2 2017 | $11,412,000 | -19.4% | 135,001 | -18.3% | 0.42% | -23.8% |
| Q1 2017 | $14,161,000 | -0.2% | 165,298 | -9.1% | 0.56% | -7.0% |
| Q4 2016 | $14,183,000 | -7.8% | 181,917 | -7.2% | 0.60% | -13.7% |
| Q3 2016 | $15,386,000 | +103.3% | 195,968 | +161.9% | 0.70% | +105.0% |
| Q2 2016 | $7,568,000 | +28.0% | 74,835 | +23.9% | 0.34% | +25.6% |
| Q1 2016 | $5,914,000 | +56.9% | 60,404 | +49.1% | 0.27% | +11.6% |
| Q4 2015 | $3,769,000 | +10.5% | 40,518 | +1.3% | 0.24% | -27.3% |
| Q3 2015 | $3,412,000 | -10.2% | 39,983 | -9.7% | 0.33% | +9.5% |
| Q2 2015 | $3,798,000 | – | 44,301 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |